MedPath

Paclitaxel plus carboplatin for advanced or recurrent carcinosarcoma of the uterus in Japan.

Not Applicable
Conditions
advanced or recurrent carcinosarcoma
Registration Number
JPRN-UMIN000008390
Lead Sponsor
Gynecology, Tohoku University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
35
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with prior cytotoxic chemotherapy were ineligible. Patients with a history of another invasive malignancy within the previous five years other than a non-melanoma skin cancer were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Progression-free survival Overall Survival Adverse events
© Copyright 2025. All Rights Reserved by MedPath